{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:42:23Z","timestamp":1792208543369,"version":"4.4.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA280968"],"award-info":[{"award-number":["R01CA280968"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["T32CA121938"],"award-info":[{"award-number":["T32CA121938"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1245\/s10434-026-20387-9","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:25:25Z","timestamp":1786631125000},"page":"10454-10460","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bright Visualization of Primary and Metastatic Medullary Thyroid Cancer in an Orthotopic Nude Mouse Model Using a Fluorescent Humanized Anti-CEA Antibody for More Accurate Staging and Improved Resection"],"prefix":"10.1245","volume":"33","author":[{"given":"Javier","family":"Bravo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blackberrie","family":"Eddins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunidhi","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siamak","family":"Amirfakhri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin E.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thinzar M.","family":"Lwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hak Soo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Yazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0086-2159","authenticated-orcid":false,"given":"Michael","family":"Bouvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"20387_CR1","doi-asserted-by":"publisher","first-page":"S1197","DOI":"10.1016\/j.annonc.2023.09.1383","volume":"34","author":"K Jansen","year":"2023","unstructured":"Jansen K, Kornfeld L, Lennartz M, et al. 2355P Carcinoembryonic antigen (CEA) expression in human tumors: A tissue microarray study on 15,413 tumors. Ann Oncol. 2023;34:S1197.","journal-title":"Ann Oncol."},{"issue":"23","key":"20387_CR2","doi-asserted-by":"publisher","first-page":"4052","DOI":"10.3390\/cancers16234052","volume":"16","author":"K Jansen","year":"2024","unstructured":"Jansen K, Kornfeld L, Lennartz M, et al. Carcinoembryonic antigen expression in human tumors: a tissue microarray study on 13,725 tumors. Cancers (Basel). 2024;16(23):4052.","journal-title":"Cancers (Basel)."},{"issue":"6","key":"20387_CR3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","volume":"25","author":"SA Wells Jr","year":"2015","unstructured":"Wells SA Jr, Asa SL, Dralle H, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015;25(6):567\u2013610.","journal-title":"Thyroid."},{"issue":"5","key":"20387_CR4","doi-asserted-by":"publisher","first-page":"e230319","DOI":"10.1530\/ERC-23-0319","volume":"31","author":"Z Tao","year":"2024","unstructured":"Tao Z, Deng X, Guo B, Ding Z, Fan Y. Subgroup analysis of steadily increased trends in medullary thyroid carcinoma incidence and mortality in the USA, 20002020: a population-based retrospective cohort study. Endocrine-Related Cancer. 2024;31(5):e230319.","journal-title":"Endocrine-Related Cancer."},{"issue":"11","key":"20387_CR5","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nrendo.2016.110","volume":"12","author":"CM Kitahara","year":"2016","unstructured":"Kitahara CM, Sosa JA. The changing incidence of thyroid cancer. Nat Rev Endocrinol. 2016;12(11):646\u201353.","journal-title":"Nat Rev Endocrinol."},{"issue":"1","key":"20387_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13045-024-01593-y","volume":"17","author":"T Zhou","year":"2024","unstructured":"Zhou T, Wang X, Zhang J, et al. Global burden of thyroid cancer from 1990 to 2021: a systematic analysis from the Global Burden of Disease Study 2021. J Hematol Oncol. 2024;17(1):74.","journal-title":"J Hematol Oncol."},{"issue":"11","key":"20387_CR7","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1210\/clinem\/dgae279","volume":"109","author":"S Abou Azar","year":"2024","unstructured":"Abou Azar S, Tobias J, Applewhite M, Angelos P, Keutgen XM. Medullary thyroid cancer: single institute experience over 3 decades and risk factors for recurrence. J Clin Endocrinol Metab. 2024;109(11):2729\u201334.","journal-title":"J Clin Endocrinol Metab."},{"key":"20387_CR8","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1001\/jama.2017.2719","volume":"317","author":"H Lim","year":"2017","unstructured":"Lim H, Devesa S, Sosa J, Check D, Kitahara C. Trends in thyroid cancer incidence and mortality in the United States, 1974\u20132013. JAMA. 2017;317:1338\u201348.","journal-title":"JAMA."},{"issue":"1","key":"20387_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2022.101655","volume":"37","author":"L Fugazzola","year":"2023","unstructured":"Fugazzola L. Medullary thyroid cancer - An update. Best Pract Res Clin Endocrinol Metab. 2023;37(1):101655.","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"issue":"8","key":"20387_CR10","doi-asserted-by":"publisher","first-page":"925","DOI":"10.6004\/jnccn.2022.0040","volume":"20","author":"RI Haddad","year":"2022","unstructured":"Haddad RI, Bischoff L, Ball D, et al. Thyroid carcinoma, Version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2022;20(8):925\u201351.","journal-title":"J Natl Compr Cancer Netw."},{"key":"20387_CR11","unstructured":"Society AC. Thyroid cancer survival rates by type and stage. 2025; https:\/\/www.cancer.org\/cancer\/types\/thyroid-cancer\/detection-diagnosis-staging\/survival-rates.html. Accessed 1\/10, 2025."},{"issue":"3","key":"20387_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1001\/jamaoto.2023.4376","volume":"150","author":"YV Mao","year":"2024","unstructured":"Mao YV, Hughes EG, Steinmetz D, et al. Extent of surgery for medullary thyroid cancer and prevalence of occult contralateral foci. JAMA Otolaryngol Head Neck Surg. 2024;150(3):209\u201314.","journal-title":"JAMA Otolaryngol Head Neck Surg."},{"issue":"9","key":"20387_CR13","doi-asserted-by":"publisher","first-page":"6291","DOI":"10.1245\/s10434-024-15570-9","volume":"31","author":"KE Cox","year":"2024","unstructured":"Cox KE, Turner MA, Lwin TM, et al. Targeting patient-derived orthotopic gastric cancers with a fluorescent humanized anti-CEA antibody. Ann Surg Oncol. 2024;31(9):6291\u20139.","journal-title":"Ann Surg Oncol."},{"issue":"19","key":"20387_CR14","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.3390\/cancers16193341","volume":"16","author":"KH Lee","year":"2024","unstructured":"Lee KH, Cox KE, Amirfakhri S, et al. Accurate co-localization of luciferase expression and fluorescent anti-CEA antibody targeting of liver metastases in an orthotopic mouse model of colon cancer. Cancers (Basel). 2024;16(19):3341.","journal-title":"Cancers (Basel)."},{"key":"20387_CR15","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jss.2023.08.038","volume":"293","author":"KE Cox","year":"2024","unstructured":"Cox KE, Turner MA, Amirfakhri S, et al. Humanized anti-carcinoembryonic antigen antibodies brightly target and label gastric cancer in orthotopic mouse models. J Surg Res. 2024;293:701\u20138.","journal-title":"J Surg Res."},{"issue":"3","key":"20387_CR16","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s00405-023-08401-2","volume":"281","author":"H Su","year":"2024","unstructured":"Su H, Men Q, Hao J, Zhang F. Risk factor analysis of distant metastases in patients with primary medullary thyroid cancer: a population-based study. Eur Arch Otorhinolaryngol. 2024;281(3):1525\u201330.","journal-title":"Eur Arch Otorhinolaryngol."},{"issue":"9","key":"20387_CR17","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1002\/cncr.22244","volume":"107","author":"S Roman","year":"2006","unstructured":"Roman S, Lin R, Sosa JA. Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases. Cancer. 2006;107(9):2134\u201342.","journal-title":"Cancer."},{"issue":"13","key":"20387_CR18","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1245\/s10434-019-07869-9","volume":"26","author":"PM Spanheimer","year":"2019","unstructured":"Spanheimer PM, Ganly I, Chou J, et al. Long-term oncologic outcomes after curative resection of familial medullary thyroid carcinoma. Ann Surg Oncol. 2019;26(13):4423\u20139.","journal-title":"Ann Surg Oncol."},{"issue":"12","key":"20387_CR19","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1093\/oncolo\/oyad232","volume":"28","author":"AJ Papachristos","year":"2023","unstructured":"Papachristos AJ, Nicholls LE, Mechera R, et al. Management of medullary thyroid cancer: patterns of recurrence and outcomes of reoperative surgery. Oncologist. 2023;28(12):1064\u201371.","journal-title":"Oncologist."},{"issue":"4","key":"20387_CR20","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1089\/thy.2020.0167","volume":"31","author":"A Kotwal","year":"2021","unstructured":"Kotwal A, Erickson D, Geske JR, Hay ID, Castro MR. Predicting outcomes in sporadic and hereditary medullary thyroid carcinoma over two decades. Thyroid. 2021;31(4):616\u201326.","journal-title":"Thyroid."},{"issue":"9","key":"20387_CR21","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1093\/bjs\/znab106","volume":"108","author":"F Fanget","year":"2021","unstructured":"Fanget F, Demarchi MS, Maillard L, Lintis A, Decaussin M, Lifante JC. Medullary thyroid cancer outcomes in patients with undetectable versus normalized postoperative calcitonin levels. Br J Surg. 2021;108(9):1064\u201371.","journal-title":"Br J Surg."},{"issue":"2","key":"20387_CR22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.suronc.2017.03.002","volume":"26","author":"M Gutowski","year":"2017","unstructured":"Gutowski M, Framery B, Boonstra MC, et al. SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery. Surg Oncol. 2017;26(2):153\u201362.","journal-title":"Surg Oncol."},{"issue":"9","key":"20387_CR23","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1210\/jc.2017-00573","volume":"102","author":"KK Rossfeld","year":"2017","unstructured":"Rossfeld KK, Justiniano SE, Ding H, et al. Biological evaluation of a fluorescent-imaging agent for medullary thyroid cancer in an orthotopic model. J Clin Endocrinol Metab. 2017;102(9):3268\u201377.","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"20387_CR24","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fern\u00e1ndez JA, et al. QuPath: Open source software for digital pathology image analysis. Sci Rep. 2017;7(1):16878.","journal-title":"Sci Rep."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20387-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20387-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20387-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:24:51Z","timestamp":1792207491000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20387-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["20387"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20387-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"11 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RMH is a nonsalaried affiliate of AntiCancer, Inc. producing patient-derived orthotopic xenograft mouse models for contract research. PKY declares a patent covering the anti-CEA M5A antibody for fluorescence-guided surgery.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}}]}}